TBAJ-876 retains bedaquiline’s activity against subunits c and ε of mycobacterium tuberculosis F-ATP synthase
The antituberculosis drug bedaquiline (BDQ) inhibits Mycobacterium tuberculosis F-ATP synthase by interfering with two subunits. Drug binding to the c subunit stalls the rotation of the c ring, while binding to the ε subunit blocks coupling of c ring rotation to ATP synthesis at the catalytic α3:β3...
Váldodahkkit: | , , , , , , |
---|---|
Eará dahkkit: | |
Materiálatiipa: | Journal Article |
Giella: | English |
Almmustuhtton: |
2020
|
Fáttát: | |
Liŋkkat: | https://hdl.handle.net/10356/138452 |